GlassScriptPhysician profile
Yaacov Weiss
NPI 1720168842
$1,014.30
in general payments reported to CMS, 2019-2025
15 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $366 · 2024: $102 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $170.32 | 2022-2025 | Watchman Flx |
| Edwards Lifesciences Corporation | $166.20 | 2021-2024 | Pascal |
| Pfizer INC. | $136.10 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.25 | 2021-2024 | Jardiance |
| Abbott Laboratories | $80.63 | 2021-2025 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $76.62 | 2022-2025 | |
| Heartflow, INC. | $53.83 | 2022 | |
| Janssen Pharmaceuticals, INC | $42.12 | 2021 | |
| Medicomp INC | $40.71 | 2022 | |
| Merck Sharp & Dohme LLC | $33.35 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $32.92 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $26.19 | 2021 | |
| Impulse Dynamics (USA) INC. | $17.59 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.36 | 2022 | |
| G Medical Diagnostic Services, INC. | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaacov Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.